Evidence map›Paper›PMID 26152718›Full record

ArticleThe Journal of biological chemistry2015

Interleukin-2 Receptor β Thr-450 Phosphorylation Is a Positive Regulator for Receptor Complex Stability and Activation of Signaling Molecules.

Blanca E Ruiz-Medina, Jeremy A Ross, Robert A Kirken

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Blanca E Ruiz-MedinaDepartment of Biological Sciences and Border Biomedical Research Center, The University of Texas at El Paso, El Paso, Texas 79968.
Jeremy A RossDepartment of Biological Sciences and Border Biomedical Research Center, The University of Texas at El Paso, El Paso, Texas 79968.
Robert A KirkenDepartment of Biological Sciences and Border Biomedical Research Center, The University of Texas at El Paso, El Paso, Texas 79968. Electronic address: rkirken@utep.edu.
The University of Texas at El Paso · US

Funding

TCCG12MD007592 · NIMHD · UNIVERSITY OF TEXAS EL PASO · PI KIRKEN, ROBERT A. · 2012 to 2018
$19.4M
NIMHD NIH HHS 2G12MD007592NIMHD NIH HHS G12 MD007592
6 · The paper itself

Abstract

T, B, and natural killer cells are required for normal immune response and are regulated by cytokines such as IL-2. These cell signals are propagated following receptor-ligand engagement, controlling recruitment and activation of effector proteins. The IL-2 receptor β subunit (IL-2Rβ) serves in this capacity and is known to be phosphorylated. Tyrosine phosphorylation of the β chain has been studied extensively. However, the identification and putative regulatory roles for serine and threonine phosphorylation sites have yet to be fully characterized. Using LC-MS/MS and phosphospecific antibodies, a novel IL-2/IL-15 inducible IL-2Rβ phosphorylation site (Thr-450) was identified. IL-2 phosphokinetic analysis revealed that phosphorylation of IL-2Rβ Thr-450 is rapid (2.5 min), transient (peaks at 15 min), and protracted compared with receptor tyrosine phosphorylation and occurs in multiple cell types, including primary human lymphocytes. Pharmacological and siRNA-mediated inhibition of various serine/threonine kinases revealed ERK1/2 as a positive regulator, whereas purified protein phosphatase 1 (PP1), dephosphorylated Thr-450 in vitro. Reconstitution assays demonstrated that Thr-450 is important for regulating IL-2R complex formation, recruitment of JAK3, and activation of AKT and ERK1/2 and a transcriptionally active STAT5. These results provide the first evidence of the identification and functional characterization for threonine phosphorylation of an interleukin receptor.

Indexed as

Amino Acid SequenceCell LineGene Expression RegulationHumansInterleukin-2Interleukin-2 Receptor beta SubunitJanus Kinase 3Mitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Molecular Sequence DataPhosphorylationProtein Phosphatase 1Proto-Oncogene Proteins c-aktRNA, Small InterferingSerineSignal TransductionInterleukin-2Interleukin-2 Receptor beta SubunitJAK3 protein, humanJanus Kinase 3MAPK1 protein, humanMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Protein Phosphatase 1Proto-Oncogene Proteins c-aktRNA, Small InterferingSerineSTAT5 Transcription FactorThreonineTyrosinecell signalinginterleukin 2JAKlymphocyteprotein kinaseprotein phosphatasereceptor phosphorylationserine/threoninesignal transductionSTAT transcription factor

Identifiers

PMID26152718
PMCPMC4543656
OpenAlexW1919660845

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.